RaySearch Laboratories AB (publ)

OTCPK:RSLB.F Stock Report

Market Cap: US$1.3b

RaySearch Laboratories (RSLB.F) Stock Overview

A medical technology company, provides software solutions for cancer treatment worldwide. More details

RSLB.F fundamental analysis
Snowflake Score
Valuation0/6
Future Growth3/6
Past Performance6/6
Financial Health6/6
Dividends2/6

RSLB.F Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

RaySearch Laboratories AB (publ) Competitors

Price History & Performance

Summary of share price highs, lows and changes for RaySearch Laboratories
Historical stock prices
Current Share PriceSEK 32.05
52 Week HighSEK 34.70
52 Week LowSEK 12.40
Beta1.11
1 Month Change-0.42%
3 Month Changen/a
1 Year Changen/a
3 Year Change482.73%
5 Year Change264.20%
Change since IPO1,356.82%

Recent News & Updates

Recent updates

Shareholder Returns

RSLB.FUS Healthcare ServicesUS Market
7D0%-1.2%-0.1%
1Yn/a35.9%13.0%

Return vs Industry: Insufficient data to determine how RSLB.F performed against the US Healthcare Services industry.

Return vs Market: Insufficient data to determine how RSLB.F performed against the US Market.

Price Volatility

Is RSLB.F's price volatile compared to industry and market?
RSLB.F volatility
RSLB.F Average Weekly Movementn/a
Healthcare Services Industry Average Movement10.3%
Market Average Movement6.4%
10% most volatile stocks in US Market17.0%
10% least volatile stocks in US Market3.2%

Stable Share Price: RSLB.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine RSLB.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2000422Johan Lofwww.raysearchlabs.com

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. The company offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems. It also provides µ-RayStation* (Micro-RayStation), a software platform for planning and evaluation in small animal irradiation research; RayPlan, a treatment planning system; DrugLog, which verifies the identity and concentration of compounded injectables before administered to a patient; RayMigrate, allows users to convert Pinnacle patient data to RayStation format and/or to DICOM format; and machine learning and liver ablation solutions.

RaySearch Laboratories AB (publ) Fundamentals Summary

How do RaySearch Laboratories's earnings and revenue compare to its market cap?
RSLB.F fundamental statistics
Market capUS$1.27b
Earnings (TTM)US$23.52m
Revenue (TTM)US$133.21m
54.0x
P/E Ratio
9.5x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RSLB.F income statement (TTM)
RevenueSEK 1.27b
Cost of RevenueSEK 102.86m
Gross ProfitSEK 1.16b
Other ExpensesSEK 940.05m
EarningsSEK 223.62m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

Aug 08, 2025

Earnings per share (EPS)6.52
Gross Margin91.88%
Net Profit Margin17.66%
Debt/Equity Ratio0%

How did RSLB.F perform over the long term?

See historical performance and comparison

Dividends

0.9%
Current Dividend Yield
46%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/11 01:40
End of Day Share Price 2025/06/18 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

RaySearch Laboratories AB (publ) is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kristofer Liljeberg-SvenssonCarnegie Investment Bank AB
Hans MählerDNB Carnegie
Hans MählerHandelsbanken Capital Markets